title: A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase.
abstract: All knockout mouse models of urea cycle disorders die in the neonatal period or shortly thereafter. Since N-acetylglutamate synthase (NAGS) deficiency in humans can be effectively treated with N-carbamyl-l-glutamate (NCG), we sought to develop a mouse model of this disorder that could be rescued by biochemical intervention, reared to adulthood, reproduce, and become a novel animal model for hyperammonemia. Founder NAGS knockout heterozygous mice were obtained from the trans-NIH Knock-Out Mouse Project. Genotyping of the mice was performed by PCR and confirmed by Western blotting of liver and intestine. NCG and L-citrulline (Cit) were used to rescue the NAGS knockout homozygous (Nags(-/-)) pups and the rescued animals were characterized. We observed an 85% survival rate of Nags(-/-) mice when they were given intraperitoneal injections with NCG and Cit during the newborn period until weaning and supplemented subsequently with both compounds in their drinking water. This regimen has allowed for normal development, apparent health, and reproduction. Interruption of this rescue intervention resulted in the development of severe hyperammonemia and death within 48 h. In addition to hyperammonemia, interruption of rescue supplementation was associated with elevated plasma glutamine, glutamate, and lysine, and reduced citrulline, arginine, ornithine and proline levels. We conclude that NAGS deprived mouse model has been developed which can be rescued by NCG and Cit and reared to reproduction and beyond. This biochemically salvageable mouse model recapitulates the clinical phenotype of proximal urea cycle disorders and can be used as a reliable model of induced hyperammonemia by manipulating the administration of the rescue compounds.
authors.affiliation: Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC 20010, USA.
authors.forename: Emilee
authors.initials: E
authors.lastname: Senkevitch
authors.forename: Juan
authors.initials: J
authors.lastname: Cabrera-Luque
authors.forename: Hiroki
authors.initials: H
authors.lastname: Morizono
authors.forename: Ljubica
authors.initials: L
authors.lastname: Caldovic
authors.forename: Mendel
authors.initials: M
authors.lastname: Tuchman
mesh_terms: D051046:Amino-Acid N-Acetyltransferase / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001947:Breeding; D004195:Disease Models, Animal; D005260:Female; D023061:Gene Order; D018390:Gene Targeting; D005838:Genotype; D005971:Glutamates / Q000627:therapeutic use; D006801:Humans; D022124:Hyperammonemia / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics / Q000401:mortality; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010641:Phenotype
chemical_list: D005971:Glutamates; C006895:N-carbamylglutamate; D051046:Amino-Acid N-Acetyltransferase